相似文献
1
Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging.
Exp Ther Med. 2010 Jan;1(1):217-221. doi: 10.3892/etm_00000035. Epub 2010 Jan 1.
2
Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Mol Cancer. 2016 Apr 7;15:28. doi: 10.1186/s12943-016-0512-8.
3
Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Oncogene. 2012 May 10;31(19):2401-11. doi: 10.1038/onc.2011.423. Epub 2011 Sep 19.
4
Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.
J Oral Pathol Med. 2012 Feb;41(2):124-30. doi: 10.1111/j.1600-0714.2011.01081.x. Epub 2011 Sep 21.
5
Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Ann Diagn Pathol. 2017 Oct;30:36-41. doi: 10.1016/j.anndiagpath.2017.05.013. Epub 2017 May 26.
6
Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Exp Mol Pathol. 2017 Aug;103(1):71-77. doi: 10.1016/j.yexmp.2017.06.004. Epub 2017 Jun 24.
7
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
8
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Cell Mol Biol (Noisy-le-grand). 2020 Jun 5;66(3):24-31.
9
MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance.
Oral Oncol. 2015 Feb;51(2):170-7. doi: 10.1016/j.oraloncology.2014.10.017. Epub 2014 Nov 27.
10
Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Int J Oral Maxillofac Surg. 2008 Apr;37(4):372-8. doi: 10.1016/j.ijom.2007.11.021. Epub 2008 Mar 4.
引用本文的文献
1
Effect of Intrauterine Smoke Exposure on microRNA-15a Expression in Human Lung Development and Subsequent Asthma Risk.
Healthcare (Basel). 2020 Dec 4;8(4):536. doi: 10.3390/healthcare8040536.
2
Emerging Roles for NLRC5 in Immune Diseases.
Front Pharmacol. 2019 Nov 19;10:1352. doi: 10.3389/fphar.2019.01352. eCollection 2019.
3
Circulating microRNAs in head and neck cancer: a scoping review of methods.
Clin Exp Metastasis. 2019 Jun;36(3):291-302. doi: 10.1007/s10585-019-09961-6. Epub 2019 Mar 14.
4
MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.
Clin Oral Investig. 2018 Mar;22(2):571-581. doi: 10.1007/s00784-017-2317-6. Epub 2018 Jan 3.
5
MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting .
Am J Transl Res. 2017 Feb 15;9(2):520-532. eCollection 2017.
6
Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients.
Oncol Lett. 2016 Sep;12(3):1729-1736. doi: 10.3892/ol.2016.4892. Epub 2016 Jul 20.
7
Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
J Cancer Res Clin Oncol. 2016 Apr;142(4):757-66. doi: 10.1007/s00432-015-2087-y. Epub 2015 Nov 30.
8
Bioinformatics analyses combined microarray identify the deregulated microRNAs in oral cancer.
Oncol Lett. 2014 Jul;8(1):218-222. doi: 10.3892/ol.2014.2070. Epub 2014 Apr 15.
本文引用的文献
1
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
Carcinogenesis. 2009 Jun;30(6):1003-7. doi: 10.1093/carcin/bgp099. Epub 2009 Apr 20.
2
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
Am J Pathol. 2009 Mar;174(3):736-45. doi: 10.2353/ajpath.2009.080731. Epub 2009 Jan 29.
3
Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma.
J Dent Res. 2008 Nov;87(11):1063-8. doi: 10.1177/154405910808701116.
4
Global epidemiology of oral and oropharyngeal cancer.
Oral Oncol. 2009 Apr-May;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002. Epub 2008 Sep 18.
5
Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
Oral Oncol. 2009 Mar;45(3):225-33. doi: 10.1016/j.oraloncology.2008.05.021. Epub 2008 Aug 19.
6
MicroRNA and oral cancer: future perspectives.
Oral Oncol. 2008 Oct;44(10):910-4. doi: 10.1016/j.oraloncology.2008.01.002. Epub 2008 Jul 11.
7
MicroRNA expression profiles in head and neck cancer cell lines.
Biochem Biophys Res Commun. 2007 Jun 22;358(1):12-7. doi: 10.1016/j.bbrc.2007.03.201. Epub 2007 Apr 9.
8
Impaired microRNA processing enhances cellular transformation and tumorigenesis.
Nat Genet. 2007 May;39(5):673-7. doi: 10.1038/ng2003. Epub 2007 Apr 1.
9
Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
Cancer Res. 2007 Mar 15;67(6):2456-68. doi: 10.1158/0008-5472.CAN-06-2698.
10
MicroRNAs and genomic instability.
Semin Cancer Biol. 2007 Feb;17(1):65-73. doi: 10.1016/j.semcancer.2006.10.004. Epub 2006 Oct 26.
Zotero 插件